Penn Medicine Provider
Internal Medicine, Medical Genetics
Archna Bajaj, MD
4.9
(381)
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center

About me

  • Assistant Professor of Clinical Medicine (Translational Medicine and Human Genetics)

Education and training

  • Medical School: Case Western Reserve University School of Medicine
  • Residency: Temple University Hospital

What my patients think about me

Average Rating
4.9

381 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
the game plan was clear and directional.
May 2025
5.0
5.0
dr bajaj listened very carefully to my concerns and incorporated them in her decision making. she took the extra step and get me in to a nutritionist impromptu.
May 2025
5.0
5.0
same courteous service as always..
May 2025
5.0
5.0
kind, caring, listened, provided info

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Bajaj is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Marlys L. Koschinsky, Archna Bajaj, Michael B. Boffa, Dave L. Dixon, Keith C. Ferdinand, Samuel S. Gidding, Edward A. Gill, Terry A. Jacobson, Erin D. Michos, Maya S. Safarova, Daniel E. Soffer, Pam R. Taub, Michael J. Wilkinson, Don P. Wilson, Christie M. Ballantyne A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice , Journal of Clinical Lipidology, 18(3): 2024,e308-e319


Wilkinson MJ, Bajaj A, Brousseau ME, Taub PR Harnessing RNA Interference for Cholesterol Lowering: The Bench to Bedside Story of Inclisiran , JAHA, 13(6): 2024,e032031


Daniel J Rader, Archna Bajaj Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease? , JACC, 81(18): 2023,1793-1796


Archna Bajaj, Marina Cuchel From supravalvular to valvular aortic stenosis: are statins contributing tot he phenotypic shift in homozygous familial hypercholesterolemia? , European Heart Journal, 43(34): 2022,3240-3242


Bajaj A, Rader DJ. Antisense oligonucleotides for atherosclerotic disease , Nat Med, 26(4): 2020,471-472


Bajaj A, Cuchel M. Homozygous familial hypercholesterolemia: what treatments are on the horizon? , Curr Opin Lipidol, 31(3): 2020,119-124


Bajaj A, Ihegword A, Qiu C, Small AM, Wei WQ, Bastarache L, Feng Q, Kember RL, Risman M, Bloom RD, Birtwell DL, Williams H, Shaffer CM, Chen J, Center RG, Denny JC, Rader DJ, Stein CM, Damrauer SM, Susztak K. Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways , Kidney Int, 97(5): 2020,1032-1041


Bajaj A, Xie D, Cedillo-Couvert E, Charleston J, Chen J, Deo R, Feldman HI, Go AS, He J, Horwitz E, Kallem R, Rahman M, Weir MR, Anderson AH, Rader DJ; CRIC Study Investigators. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD , Am J Kidney Dis, 73(6): 2019,827-836


Rader DJ, Bajaj A, Khetarpal SA. Deep Apolipoprotein Proteomics to Uncover Mechanisms of Coronary Disease Risk , J Am Coll Cardiol, 69(7): 2017,801-804


Bajaj A, Damrauer SM, Anderson AH, Xie D, Budoff MJ, Go AS, He J, Lash JP, Ojo A, Post WS, Rahman M, Reilly MP, Saleheen D, Townsend RR, Chen J, Rader DJ; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators*. Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort) , Arterioscler Thromb Vasc Biol, 37(10): 2017


View all publications